ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
Evolva Holding SA (CE)

Evolva Holding SA (CE) (ELVAF)

0.90
0.00
(0.00%)
마감 02 12월 6:00AM

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

주요 통계 및 세부정보

가격
0.90
매수가
0.00
매도가
0.00
거래량
-
0.00 일간 변동폭 0.00
0.8221 52주 범위 1.10
market_cap
전일 종가
0.90
개장가
-
최근 거래 시간
마지막 거래 시간
재정 규모
-
VWAP
-
평균 볼륨(3m)
97
발행 주식
7,230,626
배당수익률
-
주가수익률
-0.15
주당순이익(EPS)
-6
매출
15.54M
순이익
-43.37M

Evolva Holding SA (CE) 정보

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
본부
Reinach, Che
설립됨
-
Evolva Holding SA (CE) is listed in the Pharmaceutical Preparations sector of the OTC 시장 with ticker ELVAF. The last closing price for Evolva (CE) was US$0.90. Over the last year, Evolva (CE) shares have traded in a share price range of US$ 0.8221 to US$ 1.10.

Evolva (CE) currently has 7,230,626 shares in issue. The market capitalisation of Evolva (CE) is US$6.51 million. Evolva (CE) has a price to earnings ratio (PE ratio) of -0.15.

ELVAF 최신 뉴스

No news to show yet.
기간변동변동 %시가고가저가평균 일일 거래량VWAP
10000000CS
4000.90.90.91940.9CS
12-0.05-5.263157894740.950.950.9970.9CS
26-0.2-18.18181818181.11.10.93260.94574934CS
520.07799.475732879210.82211.10.82213410.91228675CS
156-36.6-97.637.576.250.151633829.5596727CS
260-36.6-97.637.592.750.152003155.45296987CS

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
AABVFAberdeen International Inc (PK)
US$ 0.03638
(0.00%)
0
AABKFAareal Bank AG (PK)
US$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
US$ 0.02275
(0.00%)
0
AAALYAareal Bank AG (PK)
US$ 34.65
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
US$ 0.55
(0.00%)
0
AABVFAberdeen International Inc (PK)
US$ 0.03638
(0.00%)
0
AABKFAareal Bank AG (PK)
US$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
US$ 0.02275
(0.00%)
0
AAALYAareal Bank AG (PK)
US$ 34.65
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
US$ 0.55
(0.00%)
0
AABVFAberdeen International Inc (PK)
US$ 0.03638
(0.00%)
0
AABKFAareal Bank AG (PK)
US$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
US$ 0.02275
(0.00%)
0
AAALYAareal Bank AG (PK)
US$ 34.65
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
US$ 0.55
(0.00%)
0

ELVAF Discussion

게시물 보기
mick mick 2 년 전
r/s
👍️0
emailcheque emailcheque 6 년 전
time for new products , new market and profit
👍️0
tykundegex tykundegex 6 년 전
Stock price down 75% since that post.. and the company has advanced considerably on both their Reservatrol and Stevia programs. With their Cargill JV, Eversweet should start to see sales ramp this Q and in 2019. With Reservatrol, very encouraging findings from the prelim results of a 2 year study (see below) and with Nootkatone a potential deal with the US CDC (and with EPA approval imminent?!).

Reservatrol Study results at 1 year:

"Preliminary results provided from an interim evaluation after 12 months (halfway) in the trial revealed significant benefits of RES vs placebo. Headline results included that RES reduced the loss of bone mineral density in the neck of the femur resulting in a 12% improvement in the FRAX t-score, a 36% reduction in hip fracture risk and a 9% reduction in the 10 year risk of a major osteoporotic fracture."

The core tech of this company is to synthesize natural compounds in yeast, but on an industrial scale, producing exact replicas of the natural compounds but with lower cost and higher purity. From what I can tell, their yeast-based process is one of the most advanced in the world, and has some decent IP to protect it.

Applications today cover reservatrol, nootkatone, stevia extracts, vanillin, and valencene, but the approach would seem to be applicable to many many other natural compounds (I'm thinking canabinoids).

I am taking a long position in Evola this week.
👍️0
tykundegex tykundegex 7 년 전
Evolva Holdings

http://www.evolva.com/mission-strategy/

Been following this co for about 5 years. It trades on the Swiss Exchange as EVE, and on the US OTC as ELVAF (although their website only mentions the US-listed ADRs as symbol ELVAY (1 ADR = 10 common shares), so I'm unsure what ELVAF is all about but it's the more liquid of the two US listings.

Today, 1 USD ~ 1 CHF so the prices (SWX:EVE and USOTC:ELVAF) are equal.

They recently completed a very large fundraising and now have about $100MM of cash in the bank, and a newly focused objective on commercialization efforts, as until recently they'd been largely an R&D outfit.

Tons of DD I could post here, but am too lazy for now. IMO a compelling long-term investment (5+ years). The stock price has come down a fair bit over the past few years, and may still see pressure from newly tradeable shares as they hit the market later this month.

For reasons unknown to me, their PR's all have the following clause, so I'm a little leery to paste any of it on iHub as it's a US website.

"This document and the information contained herein are not for publication, distribution or release in or into (directly or indirectly) the United States, Canada, Australia or Japan or any other jurisdiction in which the publication, distribution or release would be unlawful. This document does not constitute an offer of securities for sale in or into the United States, Canada, Australia or Japan."

👍️0

최근 히스토리